Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Patients with Ovarian Cancer Suggest Using Visual Learning Aids and Simplified Language to Better Help Them Understand Genetic Testing and Counseling

September 11th 2020, 6:00pm

Article

The study results also showed that older age was significantly associated with lower cancer genetics knowledge, which, according to a post-doctoral research fellow at Dana-Farber Cancer Institute, is important because older adults may serve as a resource for family members who seek information about their family's health history.

Mektovi Fails to Improve Progression-Free Survival in Rare Ovarian Cancer Subset, But Shows Effective Results

September 10th 2020, 9:00pm

Article

Compared to physician’s choice of chemotherapy, the MEK inhibitor Mektovi failed to improve progression-free survival in patients with low-grade serous ovarian carcinomas. However, the study authors note Mektovi demonstrated promising results that support continued use of the treatment.

National Ovarian Cancer Coalition to Host Annual Together in Teal® Event

September 8th 2020, 3:54pm

Article

The National Ovarian Cancer Coalition to host its annual "Together in Teal®" No Boundaries National Broadcast Celebration During September awareness month on Saturday, Septemeber 26, 2020.

Lynparza Maintenance Delays Disease Progression for Advanced BRCA-Positive Ovarian Cancer

September 3rd 2020, 6:00pm

Article

Immediate treatment with Lynparza after standard surgery and chemotherapy should be considered for all patients with newly diagnosed stage 3 or 4 ovarian cancer that carries a BRCA gene mutation, even if residual disease remains, researchers have found.

Women with Endometrial and Ovarian Cancers Experience Significant Fatigue Following Surgery

August 28th 2020, 6:00pm

Article

Nearly half (48%) of the patients reported experiencing significant fatigue following their surgery. Thirty-nine percent of the patients still reported significant fatigue one year following their surgery.

CURE’s Clinical Trial Corner: August 2020

August 27th 2020, 1:00pm

Article

Here is a list of the recent trial initiations that occurred within the cancer space in August.

Mortality Rate of Patients with Gynecological Cancers and COVID-19 Similar to Age Specific Risk

August 18th 2020, 1:30pm

Article

While 75% of patients with gynecological cancers and COVID-19 will recover, new data from New York City shows specific risks for patients with cancer infected with COVID-19.

The Latest News and Updates in Ovarian Cancer

August 3rd 2020, 10:00pm

Article

A roundup of the latest news and updates for patients with ovarian cancer from CURE®.

Phase 3 Study of Tecentriq in Advanced Stage Ovarian Cancer Fails to Meet its Main Goal of Progression-Free Survival

July 14th 2020, 7:16pm

Article

Although the study failed to meet its goal of progression-free survival, overall survival data are currently not yet available, and follow-up will continue until the next planned analysis.

Surgical Removal of Fallopian Tubes to Prevent Ovarian Cancer Rapidly Rising, More Research Needed to Support Its Continued Use

July 14th 2020, 1:22am

Article

Ten percent of women who received a hysterectomy and salpingectomy, or removal of the fallopian tubes, during the study period had a family history of breast or ovarian cancer.